These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 14501581

  • 1. New phospholipase A(2) isozymes with a potential role in atherosclerosis.
    Murakami M, Kudo I.
    Curr Opin Lipidol; 2003 Oct; 14(5):431-6. PubMed ID: 14501581
    [Abstract] [Full Text] [Related]

  • 2. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
    Rosengren B, Peilot H, Umaerus M, Jönsson-Rylander AC, Mattsson-Hultén L, Hallberg C, Cronet P, Rodriguez-Lee M, Hurt-Camejo E.
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1579-85. PubMed ID: 16601231
    [Abstract] [Full Text] [Related]

  • 3. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H.
    J Biol Chem; 2002 Aug 09; 277(32):29116-24. PubMed ID: 12021277
    [Abstract] [Full Text] [Related]

  • 4. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
    Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, Havet N, Longacre S, Vargaftig BB, Béréziat G, Voelker DR, Wolf C, Touqui L.
    J Clin Invest; 1998 Sep 15; 102(6):1152-60. PubMed ID: 9739049
    [Abstract] [Full Text] [Related]

  • 5. Role of type IIA secretory phospholipase A2 in arachidonic acid metabolism.
    Kuwata H, Sawada H, Murakami M, Kudo I.
    Adv Exp Med Biol; 1999 Sep 15; 469():183-8. PubMed ID: 10667329
    [Abstract] [Full Text] [Related]

  • 6. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
    Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA.
    Arterioscler Thromb Vasc Biol; 1999 May 15; 19(5):1291-8. PubMed ID: 10323782
    [Abstract] [Full Text] [Related]

  • 7. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
    Wooton-Kee CR, Boyanovsky BB, Nasser MS, de Villiers WJ, Webb NR.
    Arterioscler Thromb Vasc Biol; 2004 Apr 15; 24(4):762-7. PubMed ID: 14962950
    [Abstract] [Full Text] [Related]

  • 8. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.
    Pruzanski W, Lambeau L, Lazdunsky M, Cho W, Kopilov J, Kuksis A.
    Biochim Biophys Acta; 2005 Sep 05; 1736(1):38-50. PubMed ID: 16122976
    [Abstract] [Full Text] [Related]

  • 9. The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.
    Korotaeva AA, Samoilova EV, Kaminny AI, Pirkova AA, Resink TJ, Erne P, Prokazova NV, Tkachuk VA, Chazov EI.
    Mol Cell Biochem; 2005 Feb 05; 270(1-2):107-13. PubMed ID: 15792359
    [Abstract] [Full Text] [Related]

  • 10. Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2.
    Hite RD, Seeds MC, Jacinto RB, Balasubramanian R, Waite M, Bass D.
    Am J Physiol; 1998 Oct 05; 275(4):L740-7. PubMed ID: 9755106
    [Abstract] [Full Text] [Related]

  • 11. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
    Menschikowski M, Hagelgans A, Siegert G.
    Prostaglandins Other Lipid Mediat; 2006 Mar 05; 79(1-2):1-33. PubMed ID: 16516807
    [Abstract] [Full Text] [Related]

  • 12. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases.
    Touqui L, Alaoui-El-Azher M.
    Curr Mol Med; 2001 Dec 05; 1(6):739-54. PubMed ID: 11899260
    [Abstract] [Full Text] [Related]

  • 13. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
    Masuda S, Murakami M, Ishikawa Y, Ishii T, Kudo I.
    Biochim Biophys Acta; 2005 Oct 01; 1736(3):200-10. PubMed ID: 16188494
    [Abstract] [Full Text] [Related]

  • 14. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.
    Bostrom MA, Boyanovsky BB, Jordan CT, Wadsworth MP, Taatjes DJ, de Beer FC, Webb NR.
    Arterioscler Thromb Vasc Biol; 2007 Mar 01; 27(3):600-6. PubMed ID: 17204667
    [Abstract] [Full Text] [Related]

  • 15. Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions.
    Ishimoto Y, Yamada K, Yamamoto S, Ono T, Notoya M, Hanasaki K.
    Biochim Biophys Acta; 2003 Oct 21; 1642(3):129-38. PubMed ID: 14572896
    [Abstract] [Full Text] [Related]

  • 16. Redundant and segregated functions of granule-associated heparin-binding group II subfamily of secretory phospholipases A2 in the regulation of degranulation and prostaglandin D2 synthesis in mast cells.
    Enomoto A, Murakami M, Valentin E, Lambeau G, Gelb MH, Kudo I.
    J Immunol; 2000 Oct 01; 165(7):4007-14. PubMed ID: 11034411
    [Abstract] [Full Text] [Related]

  • 17. Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?
    Niessen HW, Krijnen PA, Visser CA, Meijer CJ, Erik Hack C.
    Cardiovasc Res; 2003 Oct 15; 60(1):68-77. PubMed ID: 14522408
    [Abstract] [Full Text] [Related]

  • 18. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.
    Ghesquiere SA, Gijbels MJ, Anthonsen M, van Gorp PJ, van der Made I, Johansen B, Hofker MH, de Winther MP.
    J Lipid Res; 2005 Feb 15; 46(2):201-10. PubMed ID: 15576846
    [Abstract] [Full Text] [Related]

  • 19. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins.
    Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberg E, Johansen B.
    Arterioscler Thromb Vasc Biol; 1997 Feb 15; 17(2):300-9. PubMed ID: 9081685
    [Abstract] [Full Text] [Related]

  • 20. Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis.
    Schiering A, Menschikowski M, Mueller E, Jaross W.
    Atherosclerosis; 1999 May 15; 144(1):73-8. PubMed ID: 10381280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.